Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Share-based Compensation: 2010-2022

Historic Share-based Compensation for China Pharma Holdings (CPHI) over the last 5 years, with Dec 2022 value amounting to $78,270.

  • China Pharma Holdings' Share-based Compensation fell 43.47% to $128,024 in Q1 2014 from the same period last year, while for Mar 2014 it was $213,256, marking a year-over-year decrease of 49.86%. This contributed to the annual value of $78,270 for FY2022, which is 413.48% up from last year.
  • Latest data reveals that China Pharma Holdings reported Share-based Compensation of $78,270 as of FY2022, which was up 413.48% from $15,243 recorded in FY2021.
  • Over the past 5 years, China Pharma Holdings' Share-based Compensation peaked at $78,270 during FY2022, and registered a low of $15,243 during FY2021.
  • In the last 2 years, China Pharma Holdings' Share-based Compensation had a median value of $46,756 in 2021 and averaged $46,756.
  • Data for China Pharma Holdings' Share-based Compensation shows a peak YoY skyrocketed of 413.48% (in 2022) over the last 5 years.
  • China Pharma Holdings' Share-based Compensation (Yearly) stood at $15,243 in 2021, then spiked by 413.48% to $78,270 in 2022.